<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T03:06:39Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2072/456323" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2072/456323</identifier><datestamp>2026-03-26T04:03:11Z</datestamp><setSpec>com_2072_98</setSpec><setSpec>col_2072_378192</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Electronegative LDL Promotes Inflammation and Triglyceride Accumulation in Macrophages</dc:title>
   <dc:creator>Puig Grifol, Núria</dc:creator>
   <dc:creator>Montolio, Lara</dc:creator>
   <dc:creator>Camps-Renom, Pol</dc:creator>
   <dc:creator>Navarra, Laia</dc:creator>
   <dc:creator>Jiménez Altayó, Francesc</dc:creator>
   <dc:creator>Jiménez Xarrié, Elena</dc:creator>
   <dc:creator>Sánchez Quesada, José Luis</dc:creator>
   <dc:creator>Benitez, Sonia</dc:creator>
   <dc:creator>Universitat Autònoma de Barcelona</dc:creator>
   <dc:subject>HDL</dc:subject>
   <dc:subject>TLR4</dc:subject>
   <dc:subject>Electronegative LDL</dc:subject>
   <dc:subject>Foam cells</dc:subject>
   <dc:subject>Inflammation</dc:subject>
   <dc:subject>Lipid droplets</dc:subject>
   <dc:subject>Macrophages</dc:subject>
   <dc:subject>Scavenger receptors</dc:subject>
   <dc:subject>Triglycerides</dc:subject>
   <dcterms:abstract>Altres ajuts: This research was funded by grants 158/U/2017 from Fundacio La Marato TV3.</dcterms:abstract>
   <dcterms:abstract>Electronegative low-density lipoprotein (LDL) (LDL(-)), a modified LDL that is present in blood and exerts atherogenic effects on endothelial cells and monocytes. This study aimed to determine the action of LDL(-) on monocytes differentiated into macrophages. LDL(-) and in vitro-modified LDLs (oxidized, aggregated, and acetylated) were added to macrophages derived from THP1 monocytes over-expressing CD14 (THP1-CD14). Then, cytokine release, cell differentiation, lipid accumulation, and gene expression were measured by ELISA, flow cytometry, thin-layer chromatography, and real-time PCR, respectively. LDL(-) induced more cytokine release in THP1-CD14 macrophages than other modified LDLs. LDL(-) also promoted morphological changes ascribed to differentiated macrophages. The addition of high-density lipoprotein (HDL) and anti-TLR4 counteracted these effects. LDL(-) was highly internalized by macrophages, and it was the major inductor of intracellular lipid accumulation in triglyceride-enriched lipid droplets. In contrast to inflammation, the addition of anti-TLR4 had no effect on lipid accumulation, thus suggesting an uptake pathway alternative to TLR4. In this regard, LDL(-) upregulated the expression of the scavenger receptors CD36 and LOX-1, as well as several genes involved in triglyceride (TG) accumulation. The importance and novelty of the current study is that LDL(-), a physiologically modified LDL, exerted atherogenic effects in macrophages by promoting differentiation, inflammation, and triglyceride-enriched lipid droplets formation in THP1-CD14 macrophages, probably through different receptors.</dcterms:abstract>
   <dcterms:issued>2020</dcterms:issued>
   <dc:type>Article</dc:type>
   <dc:relation>Instituto de Salud Carlos III PI16-00471</dc:relation>
   <dc:relation>Instituto de Salud Carlos III CB07-08-0016</dc:relation>
   <dc:relation>Instituto de Salud Carlos III RD16-0019-0010</dc:relation>
   <dc:relation>Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-1149</dc:relation>
   <dc:relation>Cells ; Vol. 9 Núm. 3 (january 2020)</dc:relation>
   <dc:rights>open access</dc:rights>
   <dc:rights>Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.</dc:rights>
   <dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:publisher/>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>